Related Experiment Video
Updated: Jul 22, 2026

Direct Imaging of ER Calcium with Targeted-Esterase Induced Dye Loading (TED)
Published on: May 7, 2013
Calcium, cell membrane, and excitation-contraction coupling.
This study investigated how muscles convert electrical signals into contractions by focusing on calcium sources in cardiac and smooth muscles. Using calcium antagonists, the researchers found that these drugs do not inhibit calcium influx as previously thought. Instead, they suggest that calcium release from the cell membrane is the main source of coupling calcium. This challenges current models of how calcium signaling works in these muscles. The findings support a revised understanding of excitation-contraction coupling in cardiac and smooth muscles.
Area of Science:
- Muscle physiology within cellular biology
- Calcium signaling in excitable tissues
- Cardiovascular and smooth muscle function
Background:
Understanding how muscles convert electrical signals into mechanical contractions remains a central goal in muscle physiology. Prior research has shown that skeletal muscle relies on intracellular calcium stores for excitation-contraction coupling. However, the source of calcium in cardiac and smooth muscles remains unclear. While some studies suggest extracellular calcium influx is involved, others propose calcium release from the cell membrane itself. This uncertainty has led to ongoing debate about the exact mechanisms in different muscle types. The role of calcium antagonists in these processes is also not fully understood. Experimental evidence has been mixed, with some findings supporting one model and others contradicting it. This gap motivated researchers to investigate whether calcium antagonists inhibit calcium influx or affect calcium release from the plasmalemma. No prior work had resolved whether the cell membrane or extracellular calcium is the primary source in cardiac and smooth muscles. This uncertainty drove the current study to clarify the role of calcium sources in excitation-contraction coupling.
Purpose Of The Study:
This study aimed to determine the primary source of calcium involved in excitation-contraction coupling in cardiac and smooth muscles. The specific problem addressed was the conflicting evidence regarding whether calcium influx or plasmalemma release is responsible. The motivation stemmed from the need to resolve discrepancies in current models of calcium signaling. By using calcium antagonists as tools, the researchers sought to distinguish between two possible sources of coupling calcium. The study focused on how these antagonists affect calcium exchange and uptake in different muscle types. The goal was to clarify whether the antagonists inhibit calcium influx or influence calcium release from the plasmalemma. This approach was chosen to test existing hypotheses about calcium dynamics in cardiac and smooth muscles. The findings could help refine models of muscle contraction and calcium regulation.
Main Methods:
The researchers used calcium antagonists, which are widely accepted tools for detecting calcium influx, to investigate their effects on calcium exchange and uptake. They tested these antagonists in cardiac and smooth muscle tissues. The study design involved measuring calcium levels under controlled conditions with and without antagonists. Experimental conditions were carefully controlled to isolate the effects of calcium antagonists. The researchers monitored calcium exchange and uptake in both muscle types to compare responses. They analyzed whether the antagonists influenced calcium influx or plasmalemma release. The methods included measuring changes in calcium concentration using established techniques. The results were compared to existing models of calcium signaling in muscle cells.
Main Results:
Calcium antagonists had no effect on calcium exchange or uptake in cardiac and smooth muscles. This finding suggests that the antagonists do not inhibit calcium influx as previously assumed. The results showed that the amount of coupling calcium was reduced despite unchanged calcium influx. These observations challenge the current understanding of how calcium antagonists function. The data indicate that the plasmalemma may be the main source of coupling calcium in these muscles. The study found no evidence supporting the idea that calcium influx is the primary mechanism. The results contradict the calcium-channel hypothesis in cardiac and smooth muscles. These findings suggest that calcium release from the plasmalemma is more significant than previously thought.
Conclusions:
The authors propose that calcium antagonists do not act by inhibiting calcium influx in cardiac and smooth muscles. They suggest that the reduction in coupling calcium is due to effects on the plasmalemma rather than extracellular calcium. This conclusion conflicts with current ideas about the mode of action of calcium antagonists. The researchers argue that the experimental support for the calcium-channel hypothesis is weak. They favor the plasmalemma as the main source of coupling calcium in these muscles. The findings suggest that calcium release from the plasmalemma is more important than previously recognized. The authors do not claim that calcium influx is irrelevant, but they emphasize the role of the plasmalemma. Their results support a revised model of excitation-contraction coupling in cardiac and smooth muscles.
Frequently Asked Questions
The study suggests that calcium release from the plasmalemma, not extracellular calcium influx, is the main source of coupling calcium in cardiac and smooth muscles.
Calcium antagonists were used to test whether they inhibit calcium influx or affect calcium release from the plasmalemma in cardiac and smooth muscles.
Calcium antagonists are widely accepted tools for detecting calcium influx, making them suitable for distinguishing between calcium sources in muscle cells.
The study proposes that calcium antagonists may reduce coupling calcium by affecting the plasmalemma rather than inhibiting calcium influx.
The plasmalemma is suggested to be the main source of coupling calcium in cardiac and smooth muscles, according to the study's findings.
The findings suggest that the plasmalemma, not extracellular calcium influx, is the primary source in cardiac and smooth muscles, conflicting with the calcium-channel hypothesis.
Related Concept Videos
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Generation of Action Potential in Skeletal Muscles
Like neurons, muscle cells are also regarded as excitable due to their capacity to change in response to stimuli, primarily due to voltage-gated ion channels embedded in their plasma membranes, which get activated by alterations in the cell's...
Excitation-Contraction Coupling in Skeletal Muscles
When an action potential...
Relaxation of Skeletal Muscles
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...

